Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Savers Value Village, Inc.SVV · Entity 4665 | General Counsel | August 05, 2026 | August 08, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Savers Value Village, Inc.
Report date August 05, 2026 · Filed August 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 14,440 |
Ending reported balance
After 2026-08-07 transaction · row 8
8 source rows · reconciled sequenceRow 1 · 2026-08-05 · Exercise / conversion · Acquired 10,000 · Balance 24,440 Row 2 · 2026-08-05 · Sale · Disposed 10,000 · Balance 14,440 F1: The sale was made pursuant to a 10b5-1 Plan adopted by the reporting person on March 18, 2026. Row 3 · 2026-08-07 · Exercise / conversion · Acquired 16,656 · Balance 31,096 Row 4 · 2026-08-07 · Exercise / conversion · Acquired 23,344 · Balance 54,440 Row 5 · 2026-08-07 · Exercise / conversion · Acquired 5,000 · Balance 59,440 Row 6 · 2026-08-07 · Sale · Disposed 15,000 · Balance 44,440 F1: The sale was made pursuant to a 10b5-1 Plan adopted by the reporting person on March 18, 2026. Row 7 · 2026-08-07 · Sale · Disposed 15,000 · Balance 29,440 F1: The sale was made pursuant to a 10b5-1 Plan adopted by the reporting person on March 18, 2026. Row 8 · 2026-08-07 · Sale · Disposed 15,000 · Balance 14,440 F1: The sale was made pursuant to a 10b5-1 Plan adopted by the reporting person on March 18, 2026. |
| Stock Options (Right to Purchase)SEC Table II · derivative / convertible security · Conversion / exercise price $1.41 · Expires 2029-06-12 | Direct | 23,344 |
Reported balance
After 2026-08-05 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2026-08-05 · Exercise / conversion · Disposed 10,000 · Balance 23,344 F2: Options previously granted under the Registrant's 2019 Management Incentive Plan. Each option represents the right to receive upon exercise one share of the Registrant's common stock subject to the applicable vesting and settlement conditions. F3: The June 12, 2019 stock option grant vested in substantially equal annual installments over five years starting March 28, 2020, and was fully vested on March 28, 2024. F4: The total outstanding excludes the portion of the original option grant that was solely performance-based, which will be reported separately. |
| Stock Options (Right to Purchase)SEC Table II · derivative / convertible security · Conversion / exercise price $3.16 · Expires 2030-12-09 | Direct | 87,514 |
Reported balance
After 2026-08-07 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2026-08-07 · Exercise / conversion · Disposed 16,656 · Balance 87,514 F2: Options previously granted under the Registrant's 2019 Management Incentive Plan. Each option represents the right to receive upon exercise one share of the Registrant's common stock subject to the applicable vesting and settlement conditions. F5: The December 9, 2020 stock option grant vested in substantially equal annual installments over five years starting December 9, 2021 and was fully vested on December 9, 2025. F4: The total outstanding excludes the portion of the original option grant that was solely performance-based, which will be reported separately. |
| Stock Options (Right to Purchase)SEC Table II · derivative / convertible security · Conversion / exercise price $1.41 · Expires 2029-06-12 | Direct | 0 |
Reported balance
After 2026-08-07 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2026-08-07 · Exercise / conversion · Disposed 23,344 · Balance 0 F2: Options previously granted under the Registrant's 2019 Management Incentive Plan. Each option represents the right to receive upon exercise one share of the Registrant's common stock subject to the applicable vesting and settlement conditions. F3: The June 12, 2019 stock option grant vested in substantially equal annual installments over five years starting March 28, 2020, and was fully vested on March 28, 2024. F4: The total outstanding excludes the portion of the original option grant that was solely performance-based, which will be reported separately. |
| Stock Options (Right to Purchase)SEC Table II · derivative / convertible security · Conversion / exercise price $1.41 · Expires 2029-06-12 | Direct | 315,912 |
Reported balance
After 2026-08-07 transaction · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · 2026-08-07 · Exercise / conversion · Disposed 5,000 · Balance 315,912 F2: Options previously granted under the Registrant's 2019 Management Incentive Plan. Each option represents the right to receive upon exercise one share of the Registrant's common stock subject to the applicable vesting and settlement conditions. F3: The June 12, 2019 stock option grant vested in substantially equal annual installments over five years starting March 28, 2020, and was fully vested on March 28, 2024. F6: The total outstanding excludes the portion of the original option grant that was solely time-based, which will be reported separately. |
Filing footnotes · ownership attribution and instrument terms
F1: The sale was made pursuant to a 10b5-1 Plan adopted by the reporting person on March 18, 2026.
F2: Options previously granted under the Registrant's 2019 Management Incentive Plan. Each option represents the right to receive upon exercise one share of the Registrant's common stock subject to the applicable vesting and settlement conditions.
F3: The June 12, 2019 stock option grant vested in substantially equal annual installments over five years starting March 28, 2020, and was fully vested on March 28, 2024.
F4: The total outstanding excludes the portion of the original option grant that was solely performance-based, which will be reported separately.
F5: The December 9, 2020 stock option grant vested in substantially equal annual installments over five years starting December 9, 2021 and was fully vested on December 9, 2025.
F6: The total outstanding excludes the portion of the original option grant that was solely time-based, which will be reported separately.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 13, 2024 Filed Mar 15, 2024 20:33 UTC | Savers Value Village, Inc. SVV · Entity 4665 | Exercise / conversionCommon Stock | 43,154 | $1.41 | $60,847.14 |
DisclosureSEC source: 0001127602-24-010268 · form4.xml · nonDerivative · entry 1 Medway Richard A. · CIK 0001977271 · General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,154 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 12, 2024 Filed Mar 14, 2024 22:40 UTC | Savers Value Village, Inc. SVV · Entity 4665 | GrantRestricted Stock Unit · Derivative | 15,228 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-010188 · form4.xml · derivative · entry 2 Medway Richard A. · CIK 0001977271 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,228 Underlying: Common Stock · 15,228 shares Expires not disclosed F3 · security: Each restricted stock unit ("RSU") represents the contingent right to receive, following vesting of the RSU, one share of the Registrant's common stock subject to the applicable vesting and settlement conditions. F4 · derivative.exercise_date: Reflects an award of restricted stock units pursuant to the Savers Value Village Omnibus Incentive Compensation Plan that are scheduled to vest in approximately one-third increments at each of March 12, 2026, March 12, 2027 and March 12, 2028. F4 · derivative.expiration_date: Reflects an award of restricted stock units pursuant to the Savers Value Village Omnibus Incentive Compensation Plan that are scheduled to vest in approximately one-third increments at each of March 12, 2026, March 12, 2027 and March 12, 2028. Read SEC document |
| March 12, 2024 Filed Mar 14, 2024 22:40 UTC | Savers Value Village, Inc. SVV · Entity 4665 | GrantOption (Right to Purchase) · Derivative | 31,315 | $0.00 Strike: $19.70 | $0.00 |
DisclosureSEC source: 0001127602-24-010188 · form4.xml · derivative · entry 1 Medway Richard A. · CIK 0001977271 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,315 Underlying: Common Stock · 31,315 shares Expires 2034-03-12 F1 · security: Each option represents the right to receive upon exercise one share of the Registrant's common stock subject to the applicable vesting conditions. F2 · derivative.exercise_date: Reflects an award of non-qualified stock options pursuant to the Savers Value Village Omnibus Incentive Compensation Plan that are scheduled to vest in approximately one-third increments on March 12, 2026, March 12, 2027 and March 12, 2028. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.